未登录 分享 收藏
分享 收藏
分享 收藏
Impact of time zero designation on estimated COVID-19 antiviral effectiveness in observational studies 时间零点定义对观察性研究中估计的COVID-19抗病毒有效性的影响 Bajema, Kristina L.; Yan, Lei; Berry, Kristin; Bui, David; Lin, Hung-Mo; Huang, Yuan; Li, Yuli; Rajeevan, Nallakkandi; Maciejewski, Matthew L.; Smith, Valerie A.; Bohnert, Amy S. B.; Hynes, Denise M.; Aslan, Mihaela; Ioannou, George N. 分享 收藏
Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare System 在大型整合医疗体系中采用Nirmatrelvir-Ritonavir治疗COVID-19的预算影响 Bui, David P.; Hynes, Denise M.; Wong, Edwin; Vergun, Robert; Yan, Lei; Li, Yuli; Rajeevan, Nallakkandi; Berry, Kristin; Lin, Hung-Mo; Huang, Yuan; Govier, Diana J.; Aslan, Mihaela; Ioannou, George; Bajema, Kristina L. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Target Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post-Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras Ioannou, George N.; Berry, Kristin; Rajeevan, Nallakkandi; Li, Yuli; Yan, Lei; Huang, Yuan; Bui, David; Hynes, Denise M.; Rowneki, Mazhgan; Hickok, Alex; Niederhausen, Meike; Shahoumian, Troy A.; Bohnert, Amy; Boyko, Edward J.; Korpak, Anna; Fox, Alexandra; Baraff, Aaron; Iwashyna, Theodore J.; Maciejewski, Matthew L.; Smith, Valerie A.; Berkowitz, Theodore S. Z.; Pura, John A.; Hebert, Paul; Wong, Edwin S.; O'Hare, Ann M.; Osborne, Thomas F.; Viglianti, Elizabeth M.; Aslan, Mihaela; Bajema, Kristina L. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Severity and Long-Term Mortality of COVID-19, Influenza, and Respiratory Syncytial Virus COVID-19、流感及呼吸道合胞病毒的严重程度与长期死亡率 Bajema, Kristina L.; Bui, David P.; Yan, Lei; Li, Yuli; Rajeevan, Nallakkandi; Vergun, Robert; Berry, Kristin; Huang, Yuan; Lin, Hung-Mo; Aslan, Mihaela; Ioannou, George N. 分享 收藏
分享 收藏
分享 收藏
Preliminary outcomes from a phase Ib/II study of the highly potent PI3K-mTOR dual inhibitor WX390 combined with toripalimab in patients with advanced cervical cancer Ib/II期研究初步结果显示,高度有效的PI3K-mTOR双抑制剂WX390与toripalimab联合应用于晚期宫颈癌患者的疗效。 Li, G.; Huang, A.; Zhao, Y.; Li, B.; Ding, Y.; Lai, S.; Zhang, J.; Zhu, H.; Li, D.; Li, Q.; Jia, X.; Qi, Y.; Li, Y.; Guo, Y. 分享 收藏
Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation 确定受益于nirmatrelvir-ritonavir的退伍军人: 目标试验模拟 Yan, Lei; Bui, David; Li, Yuli; Rajeevan, Nallakkandi; Rowneki, Mazhgan; Berry, Kristin; Argraves, Stephanie; Huang, Yuan; Hynes, Denise M.; Cunningham, Francesca; Huang, Grant D.; Aslan, Mihaela; Ioannou, George N.; Bajema, Kristina L. 分享 收藏